Lam Research (LRCX) director acquires 1,635 shares at $0
Lam Research (LRCX) disclosed an insider equity transaction by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lam Research (LRCX) disclosed an insider equity transaction by a director. On 11/07/2025, the director acquired 1,635 shares of common stock at a reported price of $0, consistent with an equity award. Following the transaction, the director beneficially owned 288,705 shares. The filing notes that this amount includes shares subject to unvested restricted stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,635 | $0.00 | $0.00 |
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LRCX report?
Does the reported ownership include unvested RSUs for LRCX?
What was the role of the reporting person at LRCX?
Was this Form 4 filed by one reporting person or a group?
AI-generated analysis. How Rhea-AI works. Not financial advice.